⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9284869 | 1.00 | — | — | |
| SCHEMBL5949334 | 0.84 | — | — | |
| SCHEMBL31683765 | 0.84 | — | — | |
| SCHEMBL29525394 | 0.84 | — | — | |
| SCHEMBL1452636 | 0.80 | — | — | |
| SCHEMBL1140740 | 0.73 | — | — | |
| Dithioerythriol SCHEMBL10602 | 0.73 | — | — | |
| Dithioerythriol SCHEMBL78922 | 0.73 | — | — | |
| Dithioerythriol SCHEMBL15611744 | 0.73 | — | — | |
| Dithioerythriol SCHEMBL3422787 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565000-B2 | In-situ reactive curing and infiltration in binder jet additive manufacturing | UT-BATTELLE, LLC (US) | 2026-03-03 | — | — | US | claimed |
| US-20240239042-A9 | IN-SITU REACTIVE CURING AND INFILTRATION IN BINDER JET ADDITIVE MANUFACTURING | U. S. DEPARTMENT OF ENERGY | 2024-07-18 | — | — | US | claimed |
| US-20240017484-A1 | IN-SITU REACTIVE CURING AND INFILTRATION IN BINDER JET ADDITIVE MANUFACTURING | UT BATTELLE LLC (US) | 2024-01-18 | — | — | US | claimed |
| US-12565000-B2 | In-situ reactive curing and infiltration in binder jet additive manufacturing | UT-BATTELLE, LLC (US) | 2026-03-03 | — | — | US | disclosed |
| US-20240239042-A9 | IN-SITU REACTIVE CURING AND INFILTRATION IN BINDER JET ADDITIVE MANUFACTURING | U. S. DEPARTMENT OF ENERGY | 2024-07-18 | — | — | US | disclosed |
| US-20240017484-A1 | IN-SITU REACTIVE CURING AND INFILTRATION IN BINDER JET ADDITIVE MANUFACTURING | UT BATTELLE LLC (US) | 2024-01-18 | — | — | US | disclosed |
| US-9873901-B2 | Compositions and methods for reverse transcriptase-polymerase chain reaction (RT-PCR) | Life Technologies Corporation (US) | 2018-01-23 | — | — | US | disclosed |
| EP-2100507-B1 | QUINAZOLINE DERIVATIVES CAPABLE OF INHIBITING CYTOKININ SIGNALING | SUMITOMO CHEMICAL CO (JP) | 2015-02-25 | — | — | EP | disclosed |
| US-8722580-B2 | Agent for inhibiting cytokinin signaling | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-05-13 | — | — | US | disclosed |
| US-20100056377-A1 | AGENT FOR INHIBITING CYTOKININ SIGNALING | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-04 | — | — | US | disclosed |
| EP-2100507-A1 | SUBSTANCE CAPABLE OF INHIBITING CYTOKININ SIGNALING | Sumitomo Chemical Company, Limited (JP) | 2009-09-16 | — | — | EP | disclosed |